Sera Prognostics SERA
NASDAQ SERA
$2.07 +0.08 (+4.02%)
As of: Aug 20, 2026 · 3:59 PM EDT

Sera Prognostics (SERA) Current Deferred Revenue (2021 - 2026)

Sera Prognostics' (SERA) quarterly Current Deferred Revenue came in at $20.3 million in Q1 2026, little changed YoY from $20.2 million in Q1 2025, and little changed on a QoQ basis from $20.3 million in Q4 2025.

Sera Prognostics (SERA) Current Deferred Revenue (2021 - 2026) Analysis & Trends

Sera Prognostics (SERA) has 6 years of Current Deferred Revenue data on file, last reported at $20.3 million in Q1 2026.

  • Quarterly Current Deferred Revenue changed 0.44% year-over-year to $20.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.3 million (changed 0.44% YoY) and the FY2025 annual result came in at $20.3 million, changed 0.45% from the prior year.
  • Current Deferred Revenue held at $20.3 million in Q1 2026, from $20.3 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $20.3 million in Q3 2025 to a low of $3.1 million in Q2 2022.
  • A 5-year average of $16.1 million and a median of $20.2 million in 2024 frame the typical range for Current Deferred Revenue.
  • Annual changes were most pronounced in 2022 — Current Deferred Revenue soared 6433.81% — and 2024, when it decreased 0.06%.
  • Tracing SERA's Current Deferred Revenue over 5 years: stood at $9.1 million in 2022, then surged by 122.8% to $20.2 million in 2023, then fell by 0.06% to $20.2 million in 2024, then increased by 0.45% to $20.3 million in 2025, then fell by 0.02% to $20.3 million in 2026.
  • The last three Current Deferred Revenue figures came in at $20.3 million (Q1 2026), $20.3 million (Q4 2025), and $20.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Sera Prognostics 103.48 Mn 103.48 Mn -20,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 20.30 Mn
Mar 31, 2026 20.31 Mn
Dec 31, 2025 20.32 Mn
Sep 30, 2025 20.32 Mn
Jun 30, 2025 20.22 Mn
Mar 31, 2025 20.22 Mn
Dec 31, 2024 20.22 Mn
Sep 30, 2024 20.23 Mn
Jun 30, 2024 20.23 Mn
Mar 31, 2024 20.23 Mn
Dec 31, 2023 20.24 Mn
Sep 30, 2023 9.04 Mn
Jun 30, 2023 9.05 Mn
Mar 31, 2023 9.07 Mn
Dec 31, 2022 9.08 Mn
Jun 30, 2022 3.10 Mn
Dec 31, 2021 139,000.00
Sep 30, 2021 139,000.00
Jun 30, 2021 138,000.00